Healwell AI

Integration And Compliance Woes Will Hamper Healthtech Yet Spark Recovery

AnalystLowTarget

Not Invested

Consensus Narrative from 11 Analysts

Published

12 Aug 25

Updated

12 Aug 25

AnalystLowTarget's Fair Value

CA$2.50

44.8% undervalued

12 Aug

CA$1.38

-28.1%

-3.5%

Author's Valuation

CA$2.5

44.8% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

CA$2.5

44.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

26.42%

Healthcare Services revenue growth rate

0.27%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.97%

Calculation

CA$3.02m

Earnings '28

488.87x

PE Ratio '28

CA$1.48b

Market Cap '28

CA$1.48b

Market Cap '28

496.31m

No. shares '28

CA$2.97

Share Price '28

CA$2.97 Share Price '28

Discounted to 2025 @ 5.97% p.a.

CA$2.50

Fair Value '25